IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

65 hedge funds and large institutions have $47M invested in Insight Molecular Diagnostics Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 23 reducing their positions, and 15 closing their positions.

Holders
65
Holders Change
-11
Holders Change %
-14.47%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
10
Reduced
23
Closed
15
Calls
$52K
Puts
–
Net Calls
+$52K
Net Calls Change
-$104K

Top Buyers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$39K
2
Ameriprise
2
Ameriprise
Minnesota
$34K
3
Jane Street
3
Jane Street
New York
$22K
4
LPL Financial
4
LPL Financial
California
$101K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$726K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$527K
2
Citadel Advisors
2
Citadel Advisors
Florida
$20K
3
SSA
3
Schonfeld Strategic Advisors
New York
$547K
4
GCP
4
GSA Capital Partners
United Kingdom
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CA
76
CoreCap Advisors
Michigan
– – -5 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
LC
78
Lindbrook Capital
California
$0 86 – –
US Bancorp
79
US Bancorp
Minnesota
$0 500 – –
Simplex Trading
80
Simplex Trading
Illinois
– – – –
PSB
81
Piscataqua Savings Bank
New Hampshire
$0 500 – –
AFG
82
Albion Financial Group
Utah
$0 152 – –
1 2 3
4